Alex Ralph

Chief executive of the pharmaceutical company says the sales target for 2030 ‘assumes successes and setbacks’ along the way after drug trial setback

Sir Pascal Soriot says AI ‘will make people faster and smarter’ and he does not expect ‘a big reduction of headcount’ in his industry

The pharmaceutical company said moving R&D from Stevenage after 30 years will help to deliver new, competitive treatments but would mean job losses

Chairman tells MPs the payment was a necessary incentive for Steve Buck to join the company

Cambridge Aerospace raises $300m in latest funding round as it develops Skyhammer and Starhammer interceptor systems ‘to protect Allied skies’

City regulator orders Paul Taylor to pay £489,000 for falsifying documents claiming ownership of a €200 million bond portfolio

The drug company’s decision to move its research hub to Cambridge is a blow to the town’s science ecosystem and economy. Can it survive?

John Rogers has stepped down from the board and will leave next month following the introduction of a controversial pay policy for US-based executives

Government agreed to double spending on medicines for tariff exemptions on exports to the US but MPs want to know financial impact on NHS services

Disappointing sales of erectile dysfunction gel and the termination of a US commercial agreement have led to a cash crunch and collapse of the share price